Literature DB >> 3026291

Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on cell- and antibody-mediated immunity.

G Wittmann, V Ohlinger.   

Abstract

SCC, ADV-SCC, ADV-ADCC and ADV-LYST as well as ND50-titres of neutralizing serum antibodies were examined in 36 passively immune pigs, 25 of which were vaccinated at 3 weeks of age and partly revaccinated 3 weeks later. Twenty-five vaccinated animals and 8 non-immune control pigs were challenged with infectious ADV. Independent of the state of maternal immunity the cytotoxic response of the white blood cells from all the animals was low at WPP 3 but rose with increasing age. ADV-LYST occurred only in some of the animals. A single vaccination evoked no significant effect on our immune parameters, but revaccination led to higher ADV-LYST and ADV-ADCC. In pigs vaccinated at WPP 3 the neutralizing serum titres decreased gradually, similar to unvaccinated animals, indicating that the antibodies were of maternal origin. However, after vaccination at WPP 6, no further decline of ND50-titres could be detected, pointing to a limited antibody production. Animals vaccinated at WPP 3 and revaccinated 3 weeks later showed a significant increase of serum neutralizing titres. Whereas the controls showed typical symptoms of Aujeszky's disease, the immune animals, especially the unvaccinated passively immune pigs, showed only elevated temperatures and most of them excreted small amounts of ADV. The development of cellular immunity after infection was rather similar within the maternally immune group independent whether the animals had been vaccinated or not, but ADV-ADCC and ADV-LYST showed a more rapid progress within the vaccinated group than in the non-vaccinated group and the non-immune control group. Infection resulted in significantly higher ND50 titres in vaccinated and revaccinated animals than in unvaccinated animals, indicating a secondary response in those pigs. Thus, ADV sensitization of lymphocytes had been evoked by vaccination despite the presence of maternal antibody. The interpretation of the results was complicated by great individual and litter-dependent variations of the immune parameters.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026291     DOI: 10.1007/BF01310065

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  [IMMUNIZATION AGAINST AUJESZKY'S DISEASE. 3. VACCINATION OF BROOD SOWS WITH THE MODIFIED VIRUS WITH SPECIAL CONSIDERATION TO DIAPLACENTAL TRANSFER OF THE VIRUS AND COLOSTRAL TRANSFER OF THE ANTIBODIES].

Authors:  A ZUFFA
Journal:  Zentralbl Bakteriol Orig       Date:  1964-04

2.  Neutralizing antibody titres in pig serum after revaccination with an inactivated Aujeszky disease virus (ADV) vaccine.

Authors:  J Jakubik; G Wittmann
Journal:  Zentralbl Veterinarmed B       Date:  1978-11

3.  Peristence of sindbis virus in BHK-21 cell cultures.

Authors:  W Schwöbel; R Ahl
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

Authors:  K Kuribayashi; S Gillis; D E Kern; C S Henney
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

Review 5.  Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon.

Authors:  J Y Djeu
Journal:  J Am Vet Med Assoc       Date:  1982-11-15       Impact factor: 1.936

6.  Infectious center assay of intracellular virus and infective virus titer for equine mononuclear cells infected in vivo and in vitro with equine herpesviruses.

Authors:  S K Dutta; A C Myrup
Journal:  Can J Comp Med       Date:  1983-01

7.  Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.

Authors:  R W Braun; H K Teute; H Kirchner; K Munk
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  beta-Estradiol reduces natural killer cells in mice.

Authors:  W E Seaman; M A Blackman; T D Gindhart; J R Roubinian; J M Loeb; N Talal
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

9.  Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine.

Authors:  H S Koren; D B Amos; Y B Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Immune mechanisms against canine distemper. I. Identification of K cell against canine distemper virus infected target cells in vitro.

Authors:  C K Ho; L A Babiuk
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

View more
  5 in total

1.  Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Jürgen A Richt; Bruce H Janke; Matthew R Sandbulte; Philip C Gauger; Crystal L Loving; Richard J Webby; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 2.  The interference by maternally-derived antibody with active immunization of farm animals against foot-and-mouth disease.

Authors:  R P Kitching; J S Salt
Journal:  Br Vet J       Date:  1995 Jul-Aug

3.  Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets.

Authors:  Meggan Bandrick; Kara Theis; Thomas W Molitor
Journal:  BMC Vet Res       Date:  2014-06-05       Impact factor: 2.741

4.  Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX® EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies.

Authors:  Gyula Balka; Karla Dreckmann; György Papp; Christian Kraft
Journal:  Porcine Health Manag       Date:  2016-08-14

5.  Natural killer (NK) activity of porcine blood lymphocytes against allogeneic melanoma target cells.

Authors:  M Büttner; R Wanke; B Obermann
Journal:  Vet Immunol Immunopathol       Date:  1991-08       Impact factor: 2.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.